Simplify Asset Management Inc. Arcutis Biotherapeutics, Inc. Transaction History

Simplify Asset Management Inc.

$1.77 Billion
Q3 2025

A detailed history of Simplify Asset Management Inc. transactions in Arcutis Biotherapeutics, Inc. stock. As of the latest transaction made, Simplify Asset Management Inc. holds 317,997 shares of ARQT stock, worth $7.95 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

317,997

Previous 409,432 22.33%

Holding current value

$7.95 Million

Previous $5.74 Million 4.43%

% of portfolio

0.34%

Previous 0.34%

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 20, 2025	SELL	$13.39 - $18.85 $1.22 Million - $1.72 Million	-91,435 Reduced 22.33%	317,997 $5.99 Million
Q2 2025 Aug 07, 2025	SELL	$12.59 - $16.6 $3.16 Million - $4.17 Million	-251,125 Reduced 38.02%	409,432 $5.74 Million
Q1 2025 May 13, 2025	SELL	$11.4 - $17.29 $931,858 - $1.41 Million	-81,742 Reduced 11.01%	660,557 $10.3 Million
Q4 2024 Feb 11, 2025	BUY	$8.31 - $14.99 $6.17 Million - $11.1 Million	742,299 New	742,299 $10.3 Million

About Arcutis Biotherapeutics, Inc.

Ticker ARQT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,187,500
Market Cap $1.5B
Description
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product candidate is ARQ-151, a topical roflumilast cream that has completed Phase III clinical trials for the treatment of plaque psoriasis and atopic dermatitis. The company is also developing A...

More about ARQT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplify Asset Management Inc., based on Form 13F filings with the SEC.

News

Stay updated on Simplify Asset Management Inc. with notifications on news.

Account

Simplify Asset Management Inc. Arcutis Biotherapeutics, Inc. Transaction History